Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation

Immix Biopharma, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/23/2023 4 Chudnovsky Yekaterina (10% Owner) has filed a Form 4 on Immix Biopharma, Inc.
Txns: Granted 20,000 options to buy @ $1.8, valued at $36k
Granted 16,670 options to buy @ $1.8, valued at $30k
08/23/2023 3 Chudnovsky Yekaterina (10% Owner) has filed a Form 3 on Immix Biopharma, Inc.
08/14/2023 4 BUCHAN MELISSA JANE (Director) has filed a Form 4 on Immix Biopharma, Inc.
Txns: Granted 20,000 options @ $1.86, valued at $37.2k
08/14/2023 4 Morris Gabriel S (CFO) has filed a Form 4 on Immix Biopharma, Inc.
Txns: Granted 193,000 options @ $1.86, valued at $359k
08/14/2023 4 Rachman Ilya M (CEO and Chairman) has filed a Form 4 on Immix Biopharma, Inc.
Txns: Granted 193,000 options @ $1.86, valued at $359k
08/14/2023 4 Ng Carey (Director) has filed a Form 4 on Immix Biopharma, Inc.
Txns: Granted 20,000 options @ $1.86, valued at $37.2k
08/14/2023 4 Adams Helen C. (Director) has filed a Form 4 on Immix Biopharma, Inc.
Txns: Granted 20,000 options @ $1.86, valued at $37.2k
08/14/2023 4 Hsu Jason (Director) has filed a Form 4 on Immix Biopharma, Inc.
Txns: Granted 20,000 options @ $1.86, valued at $37.2k
08/14/2023 4 Marquet Magda (Director) has filed a Form 4 on Immix Biopharma, Inc.
Txns: Granted 20,000 options @ $1.86, valued at $37.2k
11/15/2022 4 Rachman Ilya M (CEO and Chairman) has filed a Form 4 on Immix Biopharma, Inc.
Txns: Bought 4,050 shares @ $1.019, valued at $4.1k
Bought 1,000 shares @ $0.95, valued at $950
Bought 150 shares @ $0.99, valued at $148.5
11/15/2022 4 Morris Gabriel S (CFO) has filed a Form 4 on Immix Biopharma, Inc.
Txns: Bought 5,200 shares @ $0.94, valued at $4.9k
07/22/2022 4/A Senn Sean (Under 10% owner) has filed a Form 4 on Immix Biopharma, Inc.
Txns: Sold 200 shares @ $2.75, valued at $550
07/18/2022 4 Senn Sean (10% Owner) has filed a Form 4 on Immix Biopharma, Inc.
Txns: Sold 200 shares @ $2.75, valued at $550
07/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/18/2022 4 Rachman Ilya M (CEO and Chairman) has filed a Form 4 on Immix Biopharma, Inc.
Txns: Granted 250,000 options @ $2.64, valued at $660k
07/18/2022 4 Ng Carey (Director) has filed a Form 4 on Immix Biopharma, Inc.
Txns: Granted 16,000 options @ $2.64, valued at $42.2k
07/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/18/2022 4 Hsu Jason (Director) has filed a Form 4 on Immix Biopharma, Inc.
Txns: Granted 16,000 options @ $2.64, valued at $42.2k
07/18/2022 4 Morris Gabriel S (CFO) has filed a Form 4 on Immix Biopharma, Inc.
Txns: Granted 250,000 options @ $2.64, valued at $660k
01/18/2022 3 Senn Sean (10% Owner) has filed a Form 3 on Immix Biopharma, Inc.
12/20/2021 4 Rachman Ilya M (CEO and Chairman) has filed a Form 4 on Immix Biopharma, Inc.
Txns: Bought 2,500 shares @ $5, valued at $12.5k
12/20/2021 4 Hsu Jason (Director) has filed a Form 4 on Immix Biopharma, Inc.
Txns: Converted 3,915,913 shares @ $0.85, valued at $3.3M
Bought 50,000 shares @ $5, valued at $250k
Converted convertible notes @ $0.85, valued at $0
12/20/2021 4 Torchilin Vladimir P (Scientific Co-Founder) has filed a Form 4 on Immix Biopharma, Inc.
Txns: Bought 2,200 shares @ $4.47, valued at $9.8k
Bought 3,000 shares @ $5, valued at $15k
12/20/2021 4 Morris Gabriel S (CFO) has filed a Form 4 on Immix Biopharma, Inc.
Txns: Converted 74,116 shares @ $0.85, valued at $63k
Converted 123,527 shares @ $0.85, valued at $105k
Converted 123,176 shares @ $0.85, valued at $104.7k
Bought 2,000 shares @ $5, valued at $10k
Converted convertible notes @ $0.85, valued at $0
Converted convertible notes @ $0.85, valued at $0
12/20/2021 4 Ng Carey (Director) has filed a Form 4 on Immix Biopharma, Inc.
Txns: Converted 1,000,221 shares @ $0.85, valued at $850.2k
Bought 25,000 shares @ $5, valued at $125k
Converted convertible notes @ $0.85, valued at $0
12/15/2021 3 BUCHAN MELISSA JANE (Director) has filed a Form 3 on Immix Biopharma, Inc.
12/15/2021 3 Torchilin Vladimir P (Scientific Co-Founder) has filed a Form 3 on Immix Biopharma, Inc.
12/15/2021 3 Rachman Ilya M (CEO and Chairman) has filed a Form 3 on Immix Biopharma, Inc.
12/15/2021 3 Hsu Jason (Director) has filed a Form 3 on Immix Biopharma, Inc.
12/15/2021 3 Morris Gabriel S (CFO) has filed a Form 3 on Immix Biopharma, Inc.
12/15/2021 3 Adams Helen C. (Director) has filed a Form 3 on Immix Biopharma, Inc.
12/15/2021 3 Marquet Magda (Director) has filed a Form 3 on Immix Biopharma, Inc.
12/15/2021 3 Ross Graham (CMO & Head of Clinical Dev.) has filed a Form 3 on Immix Biopharma, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy